Science & Research

Centers of Excellence in Regulatory Science and Innovation (CERSIs)

 Johns Hopkins CERSIdisclaimer icon Univ. of California San Francisco-Stanford University CERSIdisclaimer icon University of Maryland CERSIdisclaimer icon Yale University-Mayo CERSIdisclaimer icon

FDA's Centers of Excellence in Regulatory Science and Innovation (CERSIs) are collaborations between FDA and academic institutions to advance regulatory science through innovative research, education, and scientific exchanges. Evolving areas of science are promising new approaches to improving our health while demanding new ways to evaluate the safety and effectiveness of the products FDA regulates.

FDA’s Strategic Plan for Advancing Regulatory Science describes how FDA is harnessing these new technologies in collaboration with academia, industry, and other governmental agencies to develop the tools, standards, and approaches required to assess the safety, efficacy, quality, and performance of innovative products.

FDA CERSIs: University of Maryland, UCSF-Stanford, Johns Hopkins University, and Yale-Mayo Clinic

FDA CERSIs at the University of Marylanddisclaimer iconUniversity of California at San Francisco(UCSF) in a joint effort with Stanford University (UCSF-Stanford)disclaimer iconJohns Hopkins Universitydisclaimer icon, and Yale University in joint effort with Mayo Clinicdisclaimer icon are part of FDA efforts to foster a robust, collaborative, regulatory science culture to address the scientific challenges presented by revolutions in medical product development and to improve food safety and quality.

Research, Scientific Exchanges, and Professional Development

A strong in-house contingent of scientific and technical experts proficient in cutting-edge science together with a network of collaborations is key to FDA's capacity to evaluate increasingly complex products and promote innovation that addresses unmet public health needs. 

Research Priority Areas and Metrics

FDA has developed metrics to assess the impact of CERSI research and identified priority areas, based on the agency's current unmet regulatory science needs. 

Through the CERSIs, FDA offers its scientific staff a range of opportunities, including research collaborations and access to state-of-the-art science courses, workshops, and seminars. These opportunities support FDA staff engagement with the academic and medical communities in areas of mutual interest in regulatory science.

CERSI Workshops, Lecture Series and Webinars

Page Last Updated: 10/26/2018
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English